Streetbeat News

Stock Prices

BHP

FCX

HBM

RIO

SCCO

TECK

Copper stocks are experiencing a rise in share prices following the announcement of a new stimulus package by China's Central Bank.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:51 am

LDOS

WMT

WU

On CNBC's 'Halftime Report Final Trades,' Stephen Weiss recommended Leidos Holdings, Jenny Harrington highlighted Western Union's 8% dividend yield, and Joseph Terranova picked Walmart. Leidos appointed Tina Jonas to its board, Western Union missed EPS estimates, and Walmart received a Buy rating from Melius Research.

Portfolio Pulse from Avi Kapoor

September 24, 2024 | 11:50 am

BABA

BIDU

JD

NIO

PDD

Shares of US-listed Chinese companies are trading higher following the announcement of a new stimulus package by China's Central Bank.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:49 am

SNOW

Snowflake shares declined following the announcement of a $2 billion private placement of senior convertible notes.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:43 am

VSTO

Gates Capital Management, a significant shareholder of Vista Outdoor, Inc., has reiterated its intention to vote against the proposed sale of the Kinetic Group to CSG. Gates Capital owns about 9.6% of Vista Outdoor.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:41 am

FLYX

JTAI

NKLA

SES

The article highlights four industrial stocks with low RSI values, indicating they are oversold and may present buying opportunities. These stocks include Nikola Corp (NKLA), SES AI Corp (SES), Flyexclusive Inc (FLYX), and Jet.AI Inc (JTAI).

Portfolio Pulse from Avi Kapoor

September 24, 2024 | 11:38 am

WVE

Wave Life Sciences reported interim data from its Phase 2 FORWARD-53 study of WVE-N531 for Duchenne Muscular Dystrophy, showing significant dystrophin expression and good safety profile.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:32 am

CRDL

Cardiol Therapeutics has successfully achieved its target patient enrollment of 100 patients in the ARCHER Phase II trial. This trial is randomized, double-blind, and placebo-controlled, focusing on evaluating the efficacy of their treatment.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:32 am

LI

TSLA

Tesla's stock is set for more gains after erasing its losses for the year, driven by strong vehicle registration data from China. The stock rose nearly 5% on Monday and is up 0.6% for the year. Analysts expect further gains ahead of the third-quarter delivery report.

Portfolio Pulse from Shanthi Rexaline

September 24, 2024 | 11:30 am

FAASW

The trading halt status was updated at 7:30 AM ET, indicating a resumption of quotations. This update is crucial for investors tracking the affected securities.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:30 am